NO911200D0 - Fremgangsmaate for fremstilling av selektive adenosin-receptor midler. - Google Patents

Fremgangsmaate for fremstilling av selektive adenosin-receptor midler.

Info

Publication number: NO911200D0
Authority: NO; Norway
Prior art keywords: selective; procedure; preparation; receptor agents; adenosin
Prior art date: 1990-03-26

Application number

NO911200A

Other languages

English (en)

Other versions

NO911200L (no

NO177591B (no

NO177591C (no

Inventor

Norton Paul Peet

Nelson Lowell Lentz

Original Assignee

Merrell Dow Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-03-26

Filing date

1991-03-25

Publication date

1991-03-25

1991-03-25 Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma

1991-03-25 Publication of NO911200D0 publication Critical patent/NO911200D0/no

1991-09-27 Publication of NO911200L publication Critical patent/NO911200L/no

1995-07-10 Publication of NO177591B publication Critical patent/NO177591B/no

1995-10-18 Publication of NO177591C publication Critical patent/NO177591C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO911200A 1990-03-26 1991-03-25 Analogifremgangsmåte for fremstilling av terapeutisk aktive, selektive adenosin-receptormidler NO177591C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/499,111 US5047534A (en)	1990-03-26	1990-03-26	Selective adenosine receptor agents

Publications (4)

Publication Number	Publication Date
NO911200D0 true NO911200D0 (no)	1991-03-25
NO911200L NO911200L (no)	1991-09-27
NO177591B NO177591B (no)	1995-07-10
NO177591C NO177591C (no)	1995-10-18

Family

ID=23983864

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO911200A NO177591C (no)	1990-03-26	1991-03-25	Analogifremgangsmåte for fremstilling av terapeutisk aktive, selektive adenosin-receptormidler

Country Status (22)

Country	Link
US (1)	US5047534A (no)
EP (1)	EP0449175B1 (no)
JP (1)	JP3181305B2 (no)
KR (1)	KR100195368B1 (no)
CN (1)	CN1032815C (no)
AR (1)	AR247887A1 (no)
AT (1)	ATE156130T1 (no)
AU (1)	AU632914B2 (no)
CA (1)	CA2038747C (no)
DE (1)	DE69127010T2 (no)
DK (1)	DK0449175T3 (no)
ES (1)	ES2107431T3 (no)
FI (1)	FI98461C (no)
GR (1)	GR3025135T3 (no)
HU (1)	HU208824B (no)
IE (1)	IE910982A1 (no)
IL (1)	IL97656A (no)
NO (1)	NO177591C (no)
NZ (1)	NZ237484A (no)
PH (1)	PH27511A (no)
PT (1)	PT97133B (no)
ZA (1)	ZA912038B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5208240A (en) *	1991-03-12	1993-05-04	Merrell Dow Pharmaceuticals Inc.	8-substituted purines as selective adenosine receptor agents
CA2116967C (en) *	1992-07-08	2003-08-19	Fumio Suzuki	Antidepressants
ES2120025T3 (es) *	1993-02-26	1998-10-16	Merrell Pharma Inc	Derivados de xantina utilizados como antagonistas de receptores de adenosina a1.
AU6781194A (en) *	1993-05-03	1994-11-21	United States Of America, Represented By The Secretary, Department Of Health And Human Services, The	8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
WO1994026744A1 (en) *	1993-05-06	1994-11-24	Merrell Dow Pharmaceuticals Inc.	8-substituted xanthines as selective adenosine receptor agents
US5629298A (en) *	1995-03-13	1997-05-13	University Of Massachusetts Medical Center	Adenosine as a positive inotrop in the compromised heart
GB9819382D0 (en)	1998-09-04	1998-10-28	Cerebrus Ltd	Chemical compounds I
US6258794B1 (en)	1999-12-14	2001-07-10	The Mclean Hospital Corporation	Treatment of mental conditions including depression
ATE481101T1 (de) *	2003-06-10	2010-10-15	Kyowa Hakko Kirin Co Ltd	Verfahren zur behandlung von angstzuständen
WO2007036491A1 (de) *	2005-09-30	2007-04-05	Basf Aktiengesellschaft	Verfahren zur herstellung von alpha-substituierten carbonsäuren
US7592461B2 (en) *	2005-12-21	2009-09-22	Bristol-Myers Squibb Company	Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
KR102060903B1 (ko) *	2018-09-12	2019-12-30	김지훈	다중접합 도마 및 그 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1435916A (en) *	1972-05-11	1976-05-19	Beecham Group Ltd	Pharmaceutical weight-reducing compositions
SE416810C (sv) *	1977-10-14	1982-07-19	Draco Ab	Forfarande for framstellning av xantinderivat med antiallergisk aktivitet
JPS57198544A (en) *	1981-05-28	1982-12-06	Sony Corp	Manufacture of magnetic recording medium
US4593095A (en) *	1983-02-18	1986-06-03	The Johns Hopkins University	Xanthine derivatives
US4772607A (en) *	1986-05-20	1988-09-20	Warner-Lambert Company	Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US4783530A (en) *	1986-11-13	1988-11-08	Marion Laboratories, Inc.	8-arylxanthines
DE8817122U1 (de) *	1988-12-22	1993-02-04	Boehringer Ingelheim Kg, 55218 Ingelheim	Neue Xanthinderivate mit Adenosinantogenistischer Wirkung

1990
- 1990-03-26 US US07/499,111 patent/US5047534A/en not_active Expired - Fee Related
1991
- 1991-03-19 ZA ZA912038A patent/ZA912038B/xx unknown
- 1991-03-19 AU AU73537/91A patent/AU632914B2/en not_active Ceased
- 1991-03-19 NZ NZ237484A patent/NZ237484A/xx unknown
- 1991-03-20 AR AR91319262A patent/AR247887A1/es active
- 1991-03-21 CA CA002038747A patent/CA2038747C/en not_active Expired - Fee Related
- 1991-03-22 IL IL9765691A patent/IL97656A/en not_active IP Right Cessation
- 1991-03-22 PH PH42193A patent/PH27511A/en unknown
- 1991-03-25 EP EP91104668A patent/EP0449175B1/en not_active Expired - Lifetime
- 1991-03-25 NO NO911200A patent/NO177591C/no not_active IP Right Cessation
- 1991-03-25 KR KR1019910004660A patent/KR100195368B1/ko not_active IP Right Cessation
- 1991-03-25 CN CN91101892A patent/CN1032815C/zh not_active Expired - Fee Related
- 1991-03-25 AT AT91104668T patent/ATE156130T1/de not_active IP Right Cessation
- 1991-03-25 DK DK91104668.8T patent/DK0449175T3/da active
- 1991-03-25 PT PT97133A patent/PT97133B/pt not_active IP Right Cessation
- 1991-03-25 HU HU91985A patent/HU208824B/hu not_active IP Right Cessation
- 1991-03-25 IE IE098291A patent/IE910982A1/en not_active IP Right Cessation
- 1991-03-25 FI FI911420A patent/FI98461C/fi active
- 1991-03-25 ES ES91104668T patent/ES2107431T3/es not_active Expired - Lifetime
- 1991-03-25 DE DE69127010T patent/DE69127010T2/de not_active Expired - Fee Related
- 1991-03-26 JP JP08451291A patent/JP3181305B2/ja not_active Expired - Fee Related
1997
- 1997-10-22 GR GR970402767T patent/GR3025135T3/el unknown

Also Published As

Publication number	Publication date
CA2038747A1 (en)	1991-09-27
IL97656A0 (en)	1992-06-21
KR100195368B1 (ko)	1999-06-15
ES2107431T3 (es)	1997-12-01
PT97133A (pt)	1991-12-31
NO911200L (no)	1991-09-27
CN1055181A (zh)	1991-10-09
FI911420A0 (fi)	1991-03-25
NO177591B (no)	1995-07-10
PH27511A (en)	1993-08-18
CN1032815C (zh)	1996-09-18
AU7353791A (en)	1991-10-03
AR247887A1 (es)	1995-04-28
PT97133B (pt)	1998-07-31
HU208824B (en)	1994-01-28
IE910982A1 (en)	1991-10-09
HUT56570A (en)	1991-09-30
EP0449175B1 (en)	1997-07-30
GR3025135T3 (en)	1998-02-27
EP0449175A2 (en)	1991-10-02
ATE156130T1 (de)	1997-08-15
JP3181305B2 (ja)	2001-07-03
IL97656A (en)	1996-06-18
NO177591C (no)	1995-10-18
AU632914B2 (en)	1993-01-14
FI98461B (fi)	1997-03-14
EP0449175A3 (en)	1993-01-20
DE69127010D1 (de)	1997-09-04
DK0449175T3 (da)	1998-02-23
JPH04221384A (ja)	1992-08-11
CA2038747C (en)	2002-05-28
FI98461C (fi)	1997-06-25
DE69127010T2 (de)	1997-11-13
US5047534A (en)	1991-09-10
FI911420A (fi)	1991-09-27
ZA912038B (en)	1991-12-24
NZ237484A (en)	1993-10-26
KR910016752A (ko)	1991-11-05

Publication	Publication Date	Title
NO913234D0 (no)	1991-08-19	Fremgangsmaate for fremstilling av pyrazolderivater.
NO911139L (no)	1991-09-24	Fremgangsmaate for fremstilling av lavere olefiner.
NO912346L (no)	1991-12-19	Fremgangsmaate for fremstilling av aminobenzodiazepiner.
NO911122D0 (no)	1991-03-20	Fremgangsmaate for fremstilling av antihyperkolesterolemiske midler.
NO902003D0 (no)	1990-05-07	Fremgangsmaate for fremstilling av n-heteroaryl-4-quinolinaminer.
NO885454L (no)	1990-06-11	Fremgangsmaate for fremstilling av triklormonosilan.
NO901554L (no)	1990-10-08	Fremgangsmaate for fremstilling av dinatrium-cefodizim.
NO911200D0 (no)	1991-03-25	Fremgangsmaate for fremstilling av selektive adenosin-receptor midler.
NO894210L (no)	1990-04-25	Fremgangsmaate for fremstilling av kinolyloxazol-2-oner.
NO894649L (no)	1990-05-25	Fremgangsmaate for fremstilling av (s)-alfa-ethyl-2-oxo-1-pyrrolidinacetamid.
NO903275D0 (no)	1990-07-23	Fremgangsmaate for fremstilling av kromanderivater.
NO895032D0 (no)	1989-12-14	Fremgangsmaate for fremstilling av 2-benzotiazoliner.
NO903043D0 (no)	1990-07-06	Fremgangsmaate for fremstilling av kromanderivater.
NO890159D0 (no)	1989-01-13	Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler.
NO903207D0 (no)	1990-07-18	Fremgangsmaate for fremstilling av halogenaminoaromatiske derivater.
NO901424D0 (no)	1990-03-28	Fremgangsmaate for fremstilling av selektive adenosinreseptorforbindelser.
NO901067L (no)	1990-09-10	Fremgangsmaate for fremstilling av tiofener.
NO895040D0 (no)	1989-12-14	Fremgangsmaate for fremstilling av polyhydroxybenzyloxypropanolaminer.
NO900969L (no)	1990-09-04	Fremgangsmaate for fremstilling av n-allymetatrifluormetylanilin.
NO911672L (no)	1991-10-28	Fremgangsmaate for fremstilling av alkansulfonanilid-derivater.
NO892468D0 (no)	1989-06-14	Fremgangsmaate for fremstilling av polyuretanskum.
NO880127L (no)	1988-07-15	Fremgangsmaate for fremstilling av (+-)-1,2-dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1,7-dicarboxylater.
NO902363D0 (no)	1990-05-29	Fremgangsmaate for fremstilling av laktulose.
NO904070L (no)	1991-03-20	Fremgangsmaate for fremstilling av alkanfenoner.
NO890819L (no)	1989-09-04	Fremgangsmaate for fremstilling av hydroksybenzaldehyder.

Legal Events

Date	Code	Title	Description
2003-10-27	MM1K	Lapsed by not paying the annual fees	Free format text: LAPSED IN SEPTEMBER 2003